+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary/Animal Vaccines Market - Global Forecast 2026-2032- Product Image
Veterinary/Animal Vaccines Market - Global Forecast 2026-2032- Product Image
Sale

Veterinary/Animal Vaccines Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4986083
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary/Animal Vaccines Market is projected to reach USD 16.05 Billion in 2026. It is expected to continue growing at a CAGR of 6.89%, reaching USD 24.01 Billion by 2032.

Veterinary and animal vaccines are a foundational pillar of preventive animal health, food security, and zoonotic disease control. They reduce morbidity and mortality in livestock and companion animals, support antimicrobial stewardship by lowering disease-driven antibiotic use, and help protect trade continuity in sectors where outbreaks can trigger movement restrictions, culling, and export bans.

Demand is being shaped by the rising global need for safe animal protein, intensifying biosecurity requirements, expanding companion animal ownership, and government-backed disease control programs. Core vaccine categories include live attenuated, inactivated, toxoid, subunit, recombinant, vector-based, DNA, and emerging RNA platforms used across cattle, swine, poultry, aquaculture, equine, and pet health applications.

The veterinary vaccines market is increasingly defined by speed, precision, and scalability. Manufacturers and animal health stakeholders are investing in thermostability, multivalent formulations, DIVA-compatible vaccines that help differentiate infected from vaccinated animals, and platform technologies that can be adapted faster when new variants or emerging pathogens appear.

Transformative Shifts in the Animal Vaccine Landscape

The veterinary vaccines landscape is moving from reactive outbreak response toward integrated disease prevention. Governments, producers, veterinarians, and pharmaceutical organizations are aligning vaccination with surveillance, diagnostics, biosecurity, and traceability. This shift is especially visible in transboundary animal diseases such as foot-and-mouth disease, avian influenza, African swine fever research programs, rabies, brucellosis, and peste des petits ruminants.

Another major shift is the growing importance of species-specific and production-system-specific immunization. Poultry and swine operations require high-volume, cost-efficient vaccination supported by hatchery automation and herd-level protocols, while cattle and aquaculture programs increasingly emphasize disease economics, regional pathogen pressure, and cold-chain reliability. In companion animal health, preventive vaccination remains central to veterinary practice as pet ownership rises and owners seek longer, healthier animal lifespans.

Innovation is also transforming competitive positioning. Recombinant and vector vaccines are gaining relevance where conventional approaches face safety, efficacy, or differentiation challenges. At the same time, regulatory expectations for potency, safety, pharmacovigilance, and manufacturing consistency are raising barriers to entry and rewarding participants with proven quality systems.

Cumulative Impact of Artificial Intelligence on Veterinary Vaccines

Artificial intelligence is beginning to reshape veterinary vaccine discovery, development, manufacturing, and field deployment. In research, AI-enabled bioinformatics can help identify antigen candidates, compare pathogen genomes, track mutations, and support epitope mapping. These capabilities are particularly relevant for rapidly evolving pathogens and for vaccines requiring strain updates based on surveillance data.

In clinical development and production, machine learning can improve trial design, batch analytics, quality monitoring, and yield optimization. AI tools also support predictive epidemiology by integrating farm-level, climate, movement, and diagnostic data to identify disease risk patterns. This can help animal health stakeholders prioritize vaccination campaigns and optimize inventory allocation.

The cumulative impact is not replacement of scientific validation, but acceleration of evidence generation. Veterinary vaccines still require controlled studies, regulatory review, safety monitoring, and real-world effectiveness data. However, AI can shorten decision cycles and improve precision when paired with validated diagnostics, robust datasets, and responsible governance.

Key Regional Insights: Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

Asia-Pacific is a high-priority region due to its large livestock population, major poultry and aquaculture industries, and continued investment in disease control infrastructure. China and India are central to regional demand, supported by large-scale animal protein production, dairy development, and government vaccination initiatives, while Japan, South Korea, and Australia emphasize high biosecurity standards, companion animal care, and advanced biologics oversight.

North America remains a mature and innovation-led region, supported by strong veterinary infrastructure, high companion animal spending, established livestock vaccination programs, and rigorous oversight from public veterinary biologics authorities in the United States and Canada. Latin America is closely tied to cattle, poultry, and swine production, with Brazil and Mexico playing important roles in commercial vaccination, rabies prevention, and export-oriented disease control.

Europe is shaped by stringent quality, pharmacovigilance, animal welfare, and food safety frameworks, with regional harmonization influencing regulatory access and post-authorization monitoring. The Middle East is increasing attention to livestock resilience, camel and small ruminant health, poultry biosecurity, and import controls, particularly in Gulf economies. Africa has substantial unmet need, with vaccination programs central to controlling diseases that affect pastoral livelihoods, food security, and zoonotic risk, including rabies, peste des petits ruminants, and other transboundary animal diseases.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN demand is supported by poultry, swine, aquaculture, and smallholder livestock systems that require scalable vaccination models, stronger cold chains, and regionally adapted disease surveillance. The GCC is focused on biosecurity, food import resilience, and vaccination needs for camels, sheep, goats, poultry, and companion animals, with public-sector procurement remaining important in animal health planning.

The European Union is a benchmark for regulatory quality, pharmacovigilance, traceability, and One Health alignment. Policy priorities around antimicrobial resistance and animal welfare reinforce the value of preventive immunization. BRICS countries represent a large share of global livestock production and animal protein consumption, making them strategically important for volume-based adoption, local manufacturing, technology transfer, and government-backed immunization programs.

The G7 countries lead in research intensity, premium companion animal care, advanced biologics manufacturing, and high-standard regulatory science, while NATO member countries share heightened attention to biosecurity, supply-chain resilience, and preparedness for animal disease events that could disrupt food systems. Across all groups, veterinary vaccines are increasingly viewed as strategic infrastructure rather than discretionary animal health products.

Key Country Insights Across Major Veterinary Vaccine Markets

The United States leads through advanced biologics regulation, strong pet healthcare demand, and integrated livestock health programs, while Canada benefits from high animal health standards and cross-border alignment in North American livestock trade. Mexico is a significant livestock and poultry market where vaccination supports productivity, rabies control, and export readiness. Brazil is one of the world’s most important animal protein producers, making cattle, poultry, and swine vaccines essential to disease prevention, biosecurity, and market access.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine mature veterinary networks with strong companion animal care and livestock disease prevention programs. Germany and France are also important centers for animal health research, quality systems, and biologics expertise. Russia’s large livestock base creates demand for domestically supplied and regionally adapted vaccines, particularly for cattle, poultry, and swine.

China and India are pivotal because of livestock scale, poultry expansion, dairy development, aquaculture relevance, and government-led disease control priorities. Japan, Australia, and South Korea are characterized by high biosecurity expectations, technologically advanced veterinary services, and strong demand for quality-assured biologics. Australia’s livestock export orientation and recognized disease-free status for several major pathogens make preventive animal health, quarantine systems, and surveillance especially important.

Actionable Recommendations for Veterinary Vaccine Industry Leaders

Industry leaders should prioritize platform-based vaccine development, stronger surveillance partnerships, and manufacturing flexibility. Recombinant, vector, and nucleic acid platforms can improve response speed, but success depends on validated efficacy, clear regulatory pathways, and scalable quality systems.

Organizations should localize strategies by species, disease burden, production model, and purchasing channel. High-volume livestock markets require affordability, reliability, and distribution strength, while companion animal markets reward veterinary trust, professional education, and clear owner communication.

Recommended actions include investing in thermostable formulations, expanding DIVA and multivalent portfolios, strengthening cold-chain visibility, using AI for surveillance-linked portfolio planning, and partnering with governments, universities, and producer organizations. Leaders should also integrate vaccine programs with diagnostics, biosecurity, and antimicrobial stewardship to demonstrate measurable value beyond product sales.

Research Methodology for Veterinary and Animal Vaccines Analysis

This executive summary is developed using a secondary research-led methodology aligned with market intelligence best practices. Inputs include publicly available information from animal health regulators, veterinary authorities, intergovernmental organizations, scientific literature, product approvals, disease control programs, vaccination guidelines, and trade-relevant biosecurity frameworks.

The analysis applies triangulation across demand drivers, disease epidemiology, regulatory structures, species-level use cases, technology platforms, and regional production systems. Emphasis is placed on verified themes rather than unsupported market sizing claims, ensuring that insights remain credible for strategic planning, market education, and executive decision-making.

Key assessment dimensions include vaccine type, route of administration, target species, disease area, end-user channel, regional policy environment, manufacturing capability, competitive innovation, and adoption constraints such as cold chain, cost, awareness, and field effectiveness.

Conclusion: Veterinary Vaccines as a One Health Growth Engine

Veterinary and animal vaccines are becoming more strategically important as the world confronts rising protein demand, zoonotic disease risk, antimicrobial resistance, and the economic impact of animal disease outbreaks. The sector is advancing from conventional vaccination models toward data-informed, platform-enabled, and regionally tailored prevention strategies.

Future progress will depend on scientific innovation, regulatory trust, field-proven efficacy, and equitable access. Organizations that combine strong biologics expertise with AI-enabled surveillance, resilient supply chains, and deep regional partnerships will be best positioned to address opportunities across livestock, aquaculture, and companion animal health.

As prevention becomes central to animal health economics and One Health policy, veterinary vaccines will remain a critical enabler of productivity, food security, trade stability, and public health protection.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Veterinary/Animal Vaccines Market, by Product Type
7.1. Introduction
7.2. Live Attenuated Vaccines
7.3. Inactivated Vaccines
7.4. Subunit & Recombinant Vaccines
7.5. Viral Vector Vaccines
8. Veterinary/Animal Vaccines Market, by Route Of Administration
8.1. Introduction
8.2. Parenteral
8.3. Oral
8.4. Topical
9. Veterinary/Animal Vaccines Market, by Disease Indication
9.1. Introduction
9.2. Viral Diseases
9.2.1. Rabies
9.2.2. Foot-and-Mouth Disease
9.2.3. Newcastle Disease
9.2.4. Canine Parvovirus
9.2.5. Canine Distemper
9.2.6. Feline Panleukopenia
9.2.7. Infectious Bovine Rhinotracheitis
9.3. Bacterial Diseases
9.3.1. Brucellosis
9.3.2. Leptospirosis
9.3.3. Clostridial Infections
9.3.4. Pasteurellosis
9.3.5. Colibacillosis
9.4. Parasitic Diseases
9.5. Fungal Infections
10. Veterinary/Animal Vaccines Market, by Technology Platform
10.1. Introduction
10.2. Conventional Vaccines
10.3. Advanced Vaccines
10.4. Novel Delivery Systems
11. Veterinary/Animal Vaccines Market, by Valency
11.1. Introduction
11.2. Monovalent Vaccines
11.3. Multivalent Vaccines
12. Veterinary/Animal Vaccines Market, by Animal Type
12.1. Introduction
12.2. Companion Animals
12.2.1. Dogs
12.2.2. Cats
12.2.3. Horses
12.3. Food-Producing Animals
12.3.1. Cattle
12.3.2. Swine
12.3.3. Poultry
12.3.4. Sheep & Goats
12.3.5. Aquaculture
12.4. Wildlife & Zoo Animals
13. Veterinary/Animal Vaccines Market, by Distribution Channel
13.1. Introduction
13.2. Veterinary Clinics
13.3. Retail Pharmacies
13.4. Online Pharmacies
14. Veterinary/Animal Vaccines Market, by End User
14.1. Introduction
14.2. Veterinary Hospitals & Clinics
14.3. Animal Farms & Production Units
14.4. Reference Laboratories
14.5. Research Institutes & Universities
14.6. Government & Public Health Agencies
15. Veterinary/Animal Vaccines Market, by Region
15.1. Asia-Pacific
15.2. Europe
15.3. North America
15.4. Latin America
15.5. Africa
15.6. Middle East
16. Veterinary/Animal Vaccines Market, by Group
16.1. NATO
16.2. G7
16.3. European Union
16.4. BRICS
16.5. ASEAN
16.6. GCC
17. Veterinary/Animal Vaccines Market, by Country
17.1. United States
17.2. China
17.3. Germany
17.4. Japan
17.5. India
17.6. United Kingdom
17.7. France
17.8. Canada
17.9. Australia
17.10. Italy
17.11. Brazil
17.12. South Korea
17.13. Mexico
17.14. Russia
17.15. Spain
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. FPNV Positioning Matrix, 2025
18.3. Market Concentration Analysis, 2025
18.3.1. Concentration Ratio (CR)
18.3.2. Herfindahl Hirschman Index (HHI)
18.4. Recent Developments & Impact Analysis, 2025
18.5. Product Portfolio Analysis, 2025
18.6. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Arko Corp.
19.2. Bimeda Biologicals Inc
19.3. Biogénesis Bagó S.A.
19.4. Biogénesis Bagó S.A.
19.5. Bioveta, a.s.
19.6. Boehringer Ingelheim International GmbH
19.7. Ceva Santé Animale
19.8. Dechra Pharmaceuticals PLC
19.9. Elanco Animal Health Incorporated
19.10. Endovac Animal Health
19.11. Hester Biosciences Limited
19.12. Hipra S.A.
19.13. Huvepharma, Inc.
19.14. Indian Immunologicals Limited
19.15. Jinyu Bio-technology Co., Ltd.
19.16. Kemin Industries, Inc.
19.17. Merck & Co., Inc.
19.18. MEVAC
19.19. Neogen Corporation
19.20. Nisseiken Co., Ltd.
19.21. Pfizer, Inc.
19.22. Phibro Animal Health Corporation
19.23. Qingdao Yebio Biological Engineering Co., Ltd.
19.24. SAN Group
19.25. Seppic by Air Liquide Healthcare
19.26. SK Bioscience
19.27. Vaxxinova
19.28. Virbac S.A.
19.29. Zoetis Inc.
List of Figures
FIGURE 1. GLOBAL VETERINARY/ANIMAL VACCINES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL VETERINARY/ANIMAL VACCINES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL VETERINARY/ANIMAL VACCINES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL VETERINARY/ANIMAL VACCINES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 9. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2032 (%)
FIGURE 13. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2025 VS 2032 (%)
FIGURE 15. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 19. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 21. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 25. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 27. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 29. GLOBAL VETERINARY/ANIMAL VACCINES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL SUBUNIT & RECOMBINANT VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL SUBUNIT & RECOMBINANT VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL SUBUNIT & RECOMBINANT VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL VIRAL VECTOR VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL VIRAL VECTOR VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL VIRAL VECTOR VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL PARENTERAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL PARENTERAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL PARENTERAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL ORAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL ORAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL VIRAL DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL VIRAL DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL VIRAL DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL RABIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL RABIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL RABIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL FOOT-AND-MOUTH DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL FOOT-AND-MOUTH DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL FOOT-AND-MOUTH DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL NEWCASTLE DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL NEWCASTLE DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL NEWCASTLE DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL CANINE PARVOVIRUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL CANINE PARVOVIRUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL CANINE PARVOVIRUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CANINE DISTEMPER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CANINE DISTEMPER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CANINE DISTEMPER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL FELINE PANLEUKOPENIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL FELINE PANLEUKOPENIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL FELINE PANLEUKOPENIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL INFECTIOUS BOVINE RHINOTRACHEITIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL INFECTIOUS BOVINE RHINOTRACHEITIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL INFECTIOUS BOVINE RHINOTRACHEITIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL BACTERIAL DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL BACTERIAL DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL BACTERIAL DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL BRUCELLOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL BRUCELLOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL BRUCELLOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL LEPTOSPIROSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL CLOSTRIDIAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL CLOSTRIDIAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL CLOSTRIDIAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL PASTEURELLOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL PASTEURELLOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL PASTEURELLOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL COLIBACILLOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL COLIBACILLOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL COLIBACILLOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL PARASITIC DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL PARASITIC DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL PARASITIC DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL CONVENTIONAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL CONVENTIONAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL CONVENTIONAL VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL ADVANCED VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL ADVANCED VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL ADVANCED VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL NOVEL DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL NOVEL DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL NOVEL DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL MONOVALENT VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL MONOVALENT VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL MONOVALENT VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL MULTIVALENT VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL MULTIVALENT VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL MULTIVALENT VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL DOGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL DOGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL CATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL CATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL HORSES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL HORSES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL HORSES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL FOOD-PRODUCING ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL FOOD-PRODUCING ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL FOOD-PRODUCING ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL CATTLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL SWINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL SWINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL POULTRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL SHEEP & GOATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL SHEEP & GOATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL SHEEP & GOATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL AQUACULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL AQUACULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL AQUACULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL WILDLIFE & ZOO ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL WILDLIFE & ZOO ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL WILDLIFE & ZOO ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL VETERINARY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL VETERINARY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL VETERINARY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL ANIMAL FARMS & PRODUCTION UNITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL ANIMAL FARMS & PRODUCTION UNITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL ANIMAL FARMS & PRODUCTION UNITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL RESEARCH INSTITUTES & UNIVERSITIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL RESEARCH INSTITUTES & UNIVERSITIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL RESEARCH INSTITUTES & UNIVERSITIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL GOVERNMENT & PUBLIC HEALTH AGENCIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL GOVERNMENT & PUBLIC HEALTH AGENCIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL GOVERNMENT & PUBLIC HEALTH AGENCIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2017-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2017-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2017-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 166. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 167. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 168. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 169. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 170. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2017-2032 (USD MILLION)
TABLE 171. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2017-2032 (USD MILLION)
TABLE 172. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 173. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2017-2032 (USD MILLION)
TABLE 174. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 175. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 176. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 177. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 178. EUROPE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 179. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 180. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 181. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 182. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 183. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2017-2032 (USD MILLION)
TABLE 184. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2017-2032 (USD MILLION)
TABLE 185. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 186. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2017-2032 (USD MILLION)
TABLE 187. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 188. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 189. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 190. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 191. NORTH AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 192. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 193. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 194. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 195. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 196. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2017-2032 (USD MILLION)
TABLE 197. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2017-2032 (USD MILLION)
TABLE 198. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 199. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2017-2032 (USD MILLION)
TABLE 200. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 201. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 202. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 203. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 204. LATIN AMERICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 205. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 206. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 207. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 208. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 209. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2017-2032 (USD MILLION)
TABLE 210. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2017-2032 (USD MILLION)
TABLE 211. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 212. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2017-2032 (USD MILLION)
TABLE 213. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 214. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 215. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 216. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 217. AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 218. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 219. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 220. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 221. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 222. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2017-2032 (USD MILLION)
TABLE 223. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2017-2032 (USD MILLION)
TABLE 224. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 225. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2017-2032 (USD MILLION)
TABLE 226. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 227. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 228. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 229. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 230. MIDDLE EAST VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 231. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 232. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 233. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 234. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 235. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 236. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2017-2032 (USD MILLION)
TABLE 237. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2017-2032 (USD MILLION)
TABLE 238. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 239. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2017-2032 (USD MILLION)
TABLE 240. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 241. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 242. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 243. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 244. NATO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 246. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 247. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 248. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 249. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2017-2032 (USD MILLION)
TABLE 250. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2017-2032 (USD MILLION)
TABLE 251. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 252. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2017-2032 (USD MILLION)
TABLE 253. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 254. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 255. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 256. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 257. G7 VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 261. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 262. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2017-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2017-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2017-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 271. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 272. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 273. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 274. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 275. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2017-2032 (USD MILLION)
TABLE 276. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2017-2032 (USD MILLION)
TABLE 277. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 278. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2017-2032 (USD MILLION)
TABLE 279. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 280. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 281. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 282. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 283. BRICS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 284. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 285. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 286. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 287. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 288. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2017-2032 (USD MILLION)
TABLE 289. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2017-2032 (USD MILLION)
TABLE 290. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 291. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2017-2032 (USD MILLION)
TABLE 292. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 293. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 294. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 295. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 296. ASEAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 297. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 298. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 299. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 300. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 301. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2017-2032 (USD MILLION)
TABLE 302. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2017-2032 (USD MILLION)
TABLE 303. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 304. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2017-2032 (USD MILLION)
TABLE 305. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 306. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 307. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 308. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 309. GCC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 310. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 311. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 312. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 313. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 314. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 315. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2017-2032 (USD MILLION)
TABLE 316. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2017-2032 (USD MILLION)
TABLE 317. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 318. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2017-2032 (USD MILLION)
TABLE 319. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 320. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 321. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 322. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 323. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 324. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 325. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 326. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 327. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 328. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2017-2032 (USD MILLION)
TABLE 329. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2017-2032 (USD MILLION)
TABLE 330. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 331. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2017-2032 (USD MILLION)
TABLE 332. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 333. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 334. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY FOOD-PRODUCING ANIMALS, 2017-2032 (USD MILLION)
TABLE 335. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 336. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 337. GERMANY VETERINARY/ANIMAL VACCINES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 338. GERMANY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 339. GERMANY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 340. GERMANY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2017-2032 (USD MILLION)
TABLE 341. GERMANY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VIRAL DISEASES, 2017-2032 (USD MILLION)
TABLE 342. GERMANY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY BACTERIAL DISEASES, 2017-2032 (USD MILLION)
TABLE 343. GERMANY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2017-2032 (USD MILLION)
TABLE 344. GERMANY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY VALENCY, 2017-2032 (USD MILLION)
TABLE 345. GERMANY VETERINARY/ANIMAL VACC

Companies Mentioned

  • Arko Corp.
  • Bimeda Biologicals Inc
  • Biogénesis Bagó S.A.
  • Biogénesis Bagó S.A.
  • Bioveta, a.s.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Endovac Animal Health
  • Hester Biosciences Limited
  • Hipra S.A.
  • Huvepharma, Inc.
  • Indian Immunologicals Limited
  • Jinyu Bio-technology Co., Ltd.
  • Kemin Industries, Inc.
  • Merck & Co., Inc.
  • MEVAC
  • Neogen Corporation
  • Nisseiken Co., Ltd.
  • Pfizer, Inc.
  • Phibro Animal Health Corporation
  • Qingdao Yebio Biological Engineering Co., Ltd.
  • SAN Group
  • Seppic by Air Liquide Healthcare
  • SK Bioscience
  • Vaxxinova
  • Virbac S.A.
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 16.05 Billion
Forecasted Market Value ( USD ) by 2032 $ 24.01 Billion
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Veterinary Vaccines Market - Global Forecast 2026-2032 - Product Image

Veterinary Vaccines Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Animal Vaccines Market - Global Forecast 2026-2032 - Product Image

Animal Vaccines Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Veterinary Vaccines - Global Strategic Business Report - Product Image

Veterinary Vaccines - Global Strategic Business Report

  • Report
  • 277 Pages
  • Global
From
Companion Animal Vaccines - Global Strategic Business Report - Product Image

Companion Animal Vaccines - Global Strategic Business Report

  • Report
  • 473 Pages
  • Global
From
Veterinary Vaccines Market by Type, Technology, Route of Administration, End User - Global Forecast to 2031 - Product Image

Veterinary Vaccines Market by Type, Technology, Route of Administration, End User - Global Forecast to 2031

  • Report
  • 430 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.